Phreesia Inc. (PHR) NEW YORK STOCK EXCHANGE INC.
$17.05 0.11 (0.65%)
Market Cap: $868M
As of 05/23/22 04:00 PM EDT. Market closed.
Phreesia Inc. (PHR) NEW YORK STOCK EXCHANGE INC.
$17.05 0.11 (0.65%)
Market Cap: $868M
As of 05/23/22 04:00 PM EDT. Market closed.
Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients and provides a modern, convenient experience, while enabling our clients to optimize their staffing, boost profitability and enhance clinical ... read more
Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients and provides a modern, convenient experience, while enabling our clients to optimize their staffing, boost profitability and enhance clinical care. read less
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
CEO
Chaim Indig
Full Time Employees
827
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
CEO
Chaim Indig
Full Time Employees
827
URL
Address
434 Fayetteville St., Suite 1400, North Carolina, Raleigh, 27601.
PRICE CHART
From:
To:
KEY STATS
Open
$17.03
Previous Close
$16.94
Days Range
$16.14 - $17.27
52 week range
$13.19 - $76.10
Volume
456,522
Avg. Volume (30 days)
859,133
Market Cap
$868M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
51,239,860
Open
$17.03
Previous Close
$16.94
Days Range
$16.14 - $17.27
52 week range
$13.19 - $76.10
Volume
456,522
Avg. Volume (30 days)
859,133
Market Cap
$868M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
51,239,860
Open in:
Open in:
INSIDER TRANSACTIONS FOR PHREESIA INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Munson Gillian | Director | May 16, 2022 | Sale | $16.06 | 2,106 | 33,815 | 16,758 | May 17, 2022, 04:19 PM |
| Munson Gillian | Director | May 09, 2022 | Option Exercise | $16.54 | 1,449 | 23,966 | 18,864 | May 11, 2022, 04:39 PM |
| Hoffman Allison C | General Counsel & Secretary | May 09, 2022 | Sale | $17.07 | 3,909 | 66,708 | 117,204 | May 11, 2022, 04:39 PM |
| Rasmussen Randy | Chief Financial Officer | Apr 30, 2022 | Option Exercise | $22.88 | 952 | 21,782 | 131,343 | May 03, 2022, 05:48 PM |
| Munson Gillian | Director | Apr 29, 2022 | Option Exercise | $22.88 | 382 | 8,740 | 20,313 | May 03, 2022, 05:48 PM |
| Goldstein Lainie | Director | Apr 29, 2022 | Option Exercise | $22.88 | 382 | 8,740 | 14,979 | May 03, 2022, 05:47 PM |
| CAHILL EDWARD L | Director | Apr 29, 2022 | Option Exercise | $22.88 | 382 | 8,740 | 29,397 | May 03, 2022, 05:47 PM |
| Indig Chaim | Chief Executive Officer | Apr 14, 2022 | Option Exercise | $27.63 | 2,917 | 80,597 | 1,245,741 | Apr 18, 2022, 04:09 PM |
| Indig Chaim | Chief Executive Officer | Apr 13, 2022 | Option Exercise | $28.73 | 9,357 | 268,827 | 1,248,658 | Apr 18, 2022, 04:09 PM |
| Roberts Evan | Chief Operating Officer | Apr 14, 2022 | Option Exercise | $27.63 | 1,706 | 47,137 | 716,840 | Apr 18, 2022, 04:08 PM |
| Roberts Evan | Chief Operating Officer | Apr 13, 2022 | Option Exercise | $28.73 | 4,724 | 135,721 | 718,546 | Apr 18, 2022, 04:08 PM |
| Rasmussen Randy | Chief Financial Officer | Apr 13, 2022 | Option Exercise | $28.73 | 3,376 | 96,992 | 133,514 | Apr 18, 2022, 04:08 PM |
| Rasmussen Randy | Chief Financial Officer | Apr 14, 2022 | Option Exercise | $27.63 | 1,219 | 33,681 | 132,295 | Apr 18, 2022, 04:08 PM |
| Davidoff Michael J. | SVP, Payer Business | Apr 14, 2022 | Option Exercise | $27.63 | 793 | 21,911 | 115,555 | Apr 18, 2022, 04:07 PM |
| Davidoff Michael J. | SVP, Payer Business | Apr 13, 2022 | Option Exercise | $28.73 | 2,053 | 58,983 | 116,348 | Apr 18, 2022, 04:07 PM |
| Linetsky David | SVP, Life Sciences | Apr 14, 2022 | Option Exercise | $27.63 | 1,315 | 36,333 | 225,800 | Apr 18, 2022, 04:07 PM |
| Linetsky David | SVP, Life Sciences | Apr 13, 2022 | Option Exercise | $28.73 | 2,254 | 64,757 | 227,115 | Apr 18, 2022, 04:07 PM |
| VanDuyn Amy Beth | SVP, Human Resources | Apr 14, 2022 | Option Exercise | $27.63 | 412 | 11,384 | 71,983 | Apr 18, 2022, 04:07 PM |
| VanDuyn Amy Beth | SVP, Human Resources | Apr 13, 2022 | Option Exercise | $28.73 | 783 | 22,496 | 72,395 | Apr 18, 2022, 04:07 PM |
| Hoffman Allison C | General Counsel & Secretary | Apr 14, 2022 | Option Exercise | $27.63 | 1,128 | 31,167 | 119,008 | Apr 18, 2022, 04:06 PM |
| Hoffman Allison C | General Counsel & Secretary | Apr 13, 2022 | Option Exercise | $28.73 | 4,098 | 117,736 | 120,136 | Apr 18, 2022, 04:06 PM |
| Rasmussen Randy | Chief Financial Officer | Mar 26, 2022 | Option Exercise | $27.78 | 52 | 1,445 | 127,637 | Mar 29, 2022, 04:34 PM |
| Indig Chaim | Chief Executive Officer | Feb 18, 2022 | Option Exercise | $5.12 | 78,106 | 399,990 | 1,239,687 | Feb 22, 2022, 04:15 PM |
| Goldstein Lainie | Director | Jan 31, 2022 | Option Exercise | $31.19 | 280 | 8,733 | 14,597 | Feb 01, 2022, 04:27 PM |
| CAHILL EDWARD L | Director | Jan 31, 2022 | Option Exercise | $31.19 | 280 | 8,733 | 29,015 | Feb 01, 2022, 04:24 PM |
| Roberts Evan | Chief Operating Officer | Jan 21, 2022 | Option Exercise | $2.03 | 25,000 | 50,750 | 714,017 | Jan 24, 2022, 04:50 PM |
| Rasmussen Randy | Chief Financial Officer | Jan 19, 2022 | Sale | $32.66 | 2,228 | 72,767 | 128,927 | Jan 21, 2022, 04:29 PM |
| VanDuyn Amy Beth | SVP, Human Resources | Jan 15, 2022 | Option Exercise | $35.55 | 2,364 | 84,040 | 71,010 | Jan 19, 2022, 06:14 PM |
| VanDuyn Amy Beth | SVP, Human Resources | Jan 17, 2022 | Option Exercise | $35.55 | 501 | 17,811 | 70,509 | Jan 19, 2022, 06:14 PM |
| Davidoff Michael J. | See remarks | Jan 17, 2022 | Option Exercise | $35.55 | 1,231 | 43,762 | 112,707 | Jan 19, 2022, 06:12 PM |
| Davidoff Michael J. | See remarks | Jan 15, 2022 | Option Exercise | $35.55 | 4,211 | 149,701 | 113,938 | Jan 19, 2022, 06:12 PM |
| Hoffman Allison C | General Counsel & Secretary | Jan 15, 2022 | Option Exercise | $35.55 | 879 | 31,248 | 116,227 | Jan 19, 2022, 06:10 PM |
| Rasmussen Randy | Chief Financial Officer | Jan 15, 2022 | Option Exercise | $35.55 | 849 | 30,182 | 129,917 | Jan 19, 2022, 06:09 PM |
| Linetsky David | SVP, Life Sciences | Jan 17, 2022 | Option Exercise | $35.55 | 416 | 14,789 | 220,116 | Jan 19, 2022, 06:06 PM |
| Linetsky David | SVP, Life Sciences | Jan 15, 2022 | Option Exercise | $35.55 | 4,251 | 151,123 | 220,532 | Jan 19, 2022, 06:06 PM |
| Roberts Evan | Chief Operating Officer | Jan 17, 2022 | Option Exercise | $35.55 | 1,743 | 61,964 | 689,017 | Jan 19, 2022, 06:05 PM |
| Roberts Evan | Chief Operating Officer | Jan 15, 2022 | Option Exercise | $35.55 | 9,543 | 339,254 | 690,760 | Jan 19, 2022, 06:05 PM |
| Indig Chaim | Chief Executive Officer | Jan 15, 2022 | Option Exercise | $35.55 | 18,438 | 655,471 | 1,200,787 | Jan 19, 2022, 06:04 PM |
| Indig Chaim | Chief Executive Officer | Jan 17, 2022 | Option Exercise | $35.55 | 39,206 | 1,393,773 | 1,161,581 | Jan 19, 2022, 06:04 PM |
| Roberts Evan | Chief Operating Officer | Jan 11, 2022 | Option Exercise | $0.84 | 43,750 | 36,750 | 646,858 | Jan 12, 2022, 06:19 PM |
| Indig Chaim | Chief Executive Officer | Jan 07, 2022 | Option Exercise | $2.03 | 84,270 | 171,068 | 1,127,805 | Jan 11, 2022, 04:17 PM |
| Linetsky David | SVP, Life Sciences | Jan 06, 2022 | Option Exercise | $5.32 | 30,950 | 164,659 | 171,338 | Jan 07, 2022, 04:16 PM |
| Rasmussen Randy | Chief Financial Officer | Dec 31, 2021 | Option Exercise | $35.41 | 342 | 12,110 | 77,321 | Jan 05, 2022, 06:49 PM |
| Hoffman Allison C | General Counsel & Secretary | Dec 31, 2021 | Option Exercise | $35.41 | 137 | 4,851 | 81,945 | Jan 05, 2022, 06:47 PM |
| Davidoff Michael J. | See remarks | Dec 31, 2021 | Option Exercise | $4.71 | 6,399 | 30,139 | 82,988 | Jan 04, 2022, 04:46 PM |
| Roberts Evan | Chief Operating Officer | Dec 09, 2021 | Option Exercise | $0.84 | 50,000 | 42,000 | 603,108 | Dec 10, 2021, 04:08 PM |
| Indig Chaim | Chief Executive Officer | Dec 09, 2021 | Option Exercise | $2.03 | 50,000 | 101,500 | 1,298,535 | Dec 10, 2021, 04:08 PM |
| Rasmussen Randy | Chief Financial Officer | Nov 09, 2021 | Sale | $73.98 | 7,185 | 531,541 | 76,979 | Nov 12, 2021, 04:12 PM |
| Linetsky David | SVP, Life Sciences | Nov 08, 2021 | Option Exercise | $4.71 | 1,499 | 7,060 | 141,887 | Nov 09, 2021, 04:50 PM |
| Linetsky David | SVP, Life Sciences | Nov 05, 2021 | Option Exercise | $4.71 | 3,478 | 16,381 | 143,866 | Nov 09, 2021, 04:50 PM |
| Linetsky David | SVP, Life Sciences | Nov 05, 2021 | Sale | $75.15 | 3,478 | 261,382 | 140,388 | Nov 09, 2021, 04:50 PM |
| Linetsky David | SVP, Life Sciences | Nov 08, 2021 | Sale | $75.12 | 1,499 | 112,607 | 140,388 | Nov 09, 2021, 04:50 PM |
| Rasmussen Randy | Chief Financial Officer | Nov 06, 2021 | Option Exercise | $73.81 | 2,862 | 211,244 | 84,164 | Nov 09, 2021, 04:50 PM |
| Linetsky David | SVP, Life Sciences | Nov 01, 2021 | Option Exercise | $4.71 | 5,451 | 25,674 | 145,839 | Nov 02, 2021, 06:37 PM |
| Linetsky David | SVP, Life Sciences | Nov 01, 2021 | Sale | $70.88 | 5,451 | 386,362 | 143,465 | Nov 02, 2021, 06:37 PM |
| Goldstein Lainie | Director | Oct 29, 2021 | Option Exercise | $70.54 | 124 | 8,747 | 14,317 | Nov 02, 2021, 06:37 PM |
| Goldstein Lainie | Director | Jul 30, 2021 | Option Exercise | $68.35 | 128 | 8,749 | 14,193 | Nov 02, 2021, 06:37 PM |
| CAHILL EDWARD L | Director | Jul 30, 2021 | Option Exercise | $68.35 | 128 | 8,749 | 28,611 | Nov 02, 2021, 06:37 PM |
| CAHILL EDWARD L | Director | Oct 29, 2021 | Option Exercise | $70.54 | 124 | 8,747 | 28,735 | Nov 02, 2021, 06:37 PM |
| VanDuyn Amy Beth | SVP, Human Resources | Oct 21, 2020 | Option Exercise | $2.03 | 9,281 | 18,840 | 61,705 | Nov 02, 2021, 06:36 PM |
| VanDuyn Amy Beth | SVP, Human Resources | Oct 21, 2020 | Sale | $35.00 | 10,834 | 379,190 | 50,871 | Nov 02, 2021, 06:36 PM |
| Linetsky David | SVP, Life Sciences | Oct 15, 2021 | Option Exercise | $4.71 | 5,452 | 25,679 | 145,840 | Oct 15, 2021, 06:33 PM |
| Linetsky David | SVP, Life Sciences | Oct 15, 2021 | Sale | $65.36 | 5,452 | 356,334 | 140,388 | Oct 15, 2021, 06:33 PM |
| Linetsky David | SVP, Life Sciences | Aug 31, 2021 | Option Exercise | $4.71 | 474 | 2,233 | 140,862 | Sep 02, 2021, 04:01 PM |
| Linetsky David | SVP, Life Sciences | Sep 01, 2021 | Option Exercise | $4.71 | 4,978 | 23,446 | 145,366 | Sep 02, 2021, 04:01 PM |
| Linetsky David | SVP, Life Sciences | Aug 31, 2021 | Sale | $71.84 | 474 | 34,052 | 140,388 | Sep 02, 2021, 04:01 PM |
| Linetsky David | SVP, Life Sciences | Sep 01, 2021 | Sale | $70.42 | 4,978 | 350,535 | 143,925 | Sep 02, 2021, 04:01 PM |
| Linetsky David | SVP, Life Sciences | Aug 27, 2021 | Option Exercise | $2.55 | 21,455 | 54,710 | 161,843 | Aug 31, 2021, 04:41 PM |
| Linetsky David | SVP, Life Sciences | Aug 27, 2021 | Sale | $71.85 | 21,455 | 1,541,599 | 157,911 | Aug 31, 2021, 04:41 PM |
| Indig Chaim | Chief Executive Officer | Aug 30, 2021 | Option Exercise | $6.17 | 54,672 | 337,361 | 1,303,207 | Aug 31, 2021, 04:41 PM |
| Indig Chaim | Chief Executive Officer | Aug 27, 2021 | Option Exercise | $4.71 | 57,556 | 271,089 | 1,306,091 | Aug 31, 2021, 04:41 PM |
| Indig Chaim | Chief Executive Officer | Aug 27, 2021 | Sale | $72.29 | 57,556 | 4,160,848 | 1,302,191 | Aug 31, 2021, 04:41 PM |
| Indig Chaim | Chief Executive Officer | Aug 30, 2021 | Sale | $71.35 | 54,672 | 3,900,870 | 1,276,834 | Aug 31, 2021, 04:41 PM |
| Linetsky David | SVP, Life Sciences | Aug 25, 2021 | Option Exercise | $2.55 | 500 | 1,275 | 140,888 | Aug 27, 2021, 08:08 PM |
| Linetsky David | SVP, Life Sciences | Aug 26, 2021 | Option Exercise | $2.55 | 800 | 2,040 | 141,188 | Aug 27, 2021, 08:08 PM |
| Linetsky David | SVP, Life Sciences | Aug 26, 2021 | Sale | $70.07 | 800 | 56,054 | 140,388 | Aug 27, 2021, 08:08 PM |
| Linetsky David | SVP, Life Sciences | Aug 25, 2021 | Sale | $70.04 | 500 | 35,019 | 140,388 | Aug 27, 2021, 08:08 PM |
| Indig Chaim | Chief Executive Officer | Aug 26, 2021 | Option Exercise | $4.71 | 800 | 3,768 | 1,249,335 | Aug 27, 2021, 08:07 PM |
| Indig Chaim | Chief Executive Officer | Aug 25, 2021 | Option Exercise | $4.71 | 600 | 2,826 | 1,249,135 | Aug 27, 2021, 08:07 PM |
| Indig Chaim | Chief Executive Officer | Aug 26, 2021 | Sale | $70.04 | 800 | 56,036 | 1,248,535 | Aug 27, 2021, 08:07 PM |
| Indig Chaim | Chief Executive Officer | Aug 25, 2021 | Sale | $70.03 | 600 | 42,018 | 1,248,535 | Aug 27, 2021, 08:07 PM |
| Hoffman Allison C | General Counsel & Secretary | Aug 24, 2021 | Option Exercise | $69.54 | 2,577 | 179,205 | 83,890 | Aug 26, 2021, 05:14 PM |
| Hoffman Allison C | General Counsel & Secretary | Aug 25, 2021 | Sale | $69.05 | 2,082 | 143,762 | 81,808 | Aug 26, 2021, 05:14 PM |
| Weintraub Michael | Director | Aug 05, 2021 | Option Exercise | $2.03 | 8,236 | 16,719 | 175,325 | Aug 09, 2021, 04:08 PM |
| Weintraub Michael | Director | Aug 05, 2021 | Sale | $70.13 | 8,236 | 577,552 | 167,089 | Aug 09, 2021, 04:08 PM |
| VanDuyn Amy Beth | SVP, Human Resources | Aug 05, 2021 | Sale | $69.58 | 5,273 | 366,877 | 55,761 | Aug 09, 2021, 04:08 PM |
| Indig Chaim | Chief Executive Officer | Aug 05, 2021 | Option Exercise | $4.71 | 28,120 | 132,445 | 1,276,655 | Aug 09, 2021, 04:08 PM |
| Indig Chaim | Chief Executive Officer | Aug 06, 2021 | Option Exercise | $4.71 | 1,660 | 7,819 | 1,250,195 | Aug 09, 2021, 04:08 PM |
| Indig Chaim | Chief Executive Officer | Aug 06, 2021 | Sale | $70.53 | 1,660 | 117,084 | 1,248,535 | Aug 09, 2021, 04:08 PM |
| Indig Chaim | Chief Executive Officer | Aug 05, 2021 | Sale | $70.27 | 28,120 | 1,976,006 | 1,248,535 | Aug 09, 2021, 04:08 PM |
| Indig Chaim | Chief Executive Officer | Jul 29, 2021 | Option Exercise | $2.45 | 6,779 | 16,613 | 1,255,314 | Aug 02, 2021, 04:05 PM |
| Indig Chaim | Chief Executive Officer | Jul 30, 2021 | Option Exercise | $4.71 | 102 | 480 | 1,248,637 | Aug 02, 2021, 04:05 PM |
| Indig Chaim | Chief Executive Officer | Jul 29, 2021 | Sale | $70.03 | 6,779 | 474,729 | 1,248,535 | Aug 02, 2021, 04:05 PM |
| Indig Chaim | Chief Executive Officer | Jul 30, 2021 | Sale | $70.00 | 102 | 7,140 | 1,248,535 | Aug 02, 2021, 04:05 PM |
| Weintraub Michael | Director | Jul 29, 2021 | Option Exercise | $2.03 | 1,754 | 3,561 | 168,843 | Aug 02, 2021, 04:03 PM |
| Weintraub Michael | Director | Jul 30, 2021 | Option Exercise | $2.03 | 10 | 20 | 167,099 | Aug 02, 2021, 04:03 PM |
| Weintraub Michael | Director | Jul 30, 2021 | Sale | $70.00 | 10 | 700 | 167,089 | Aug 02, 2021, 04:03 PM |
| Weintraub Michael | Director | Jul 29, 2021 | Sale | $70.02 | 1,754 | 122,821 | 167,089 | Aug 02, 2021, 04:03 PM |
| Weintraub Michael | Director | Jul 21, 2021 | Option Exercise | $2.03 | 2,500 | 5,075 | 169,589 | Jul 22, 2021, 04:49 PM |
| Weintraub Michael | Director | Jul 20, 2021 | Option Exercise | $2.03 | 7,500 | 15,225 | 174,589 | Jul 22, 2021, 04:49 PM |
| Weintraub Michael | Director | Jul 21, 2021 | Sale | $65.15 | 2,500 | 162,867 | 167,089 | Jul 22, 2021, 04:49 PM |
| Weintraub Michael | Director | Jul 20, 2021 | Sale | $65.08 | 7,500 | 488,137 | 167,089 | Jul 22, 2021, 04:49 PM |
| Weintraub Michael | Director | Jul 16, 2021 | Option Exercise | $2.03 | 20,000 | 40,600 | 187,089 | Jul 20, 2021, 06:12 PM |
| Weintraub Michael | Director | Jul 16, 2021 | Sale | $63.76 | 20,000 | 1,275,202 | 173,764 | Jul 20, 2021, 06:12 PM |
| Munson Gillian | Director | Jul 08, 2021 | Sale | $63.19 | 3,055 | 193,044 | 20,731 | Jul 12, 2021, 04:27 PM |
| Roberts Evan | Chief Operating Officer | Jun 28, 2021 | Sale | $60.38 | 32,075 | 1,936,756 | 553,108 | Jun 30, 2021, 04:34 PM |
| Roberts Evan | Chief Operating Officer | Jun 25, 2021 | Sale | $60.09 | 1,834 | 110,210 | 585,183 | Jun 28, 2021, 04:03 PM |
| Roberts Evan | Chief Operating Officer | Jun 24, 2021 | Sale | $60.05 | 21,091 | 1,266,500 | 587,017 | Jun 28, 2021, 04:03 PM |
| CAHILL EDWARD L | Director | Jun 24, 2021 | Sale | $60.03 | 5,000 | 300,149 | 25,878 | Jun 25, 2021, 06:00 PM |
| Pegus Cheryl | Director | May 24, 2021 | Option Exercise | $45.45 | 3,555 | 161,575 | 13,220 | May 26, 2021, 04:24 PM |
| Davidoff Michael J. | See Remarks | Apr 09, 2021 | Option Exercise | $4.71 | 2,134 | 10,051 | 78,723 | Apr 13, 2021, 05:08 PM |
| Davidoff Michael J. | See Remarks | Apr 09, 2021 | Sale | $50.51 | 2,134 | 107,784 | 76,789 | Apr 13, 2021, 05:08 PM |
| Linetsky David | SVP, Life Sciences | Mar 15, 2021 | Sale | $61.15 | 48,482 | 2,964,510 | 100,864 | Mar 17, 2021, 04:28 PM |
| Linetsky David | SVP, Life Sciences | Mar 16, 2021 | Sale | $59.71 | 1,578 | 94,224 | 93,380 | Mar 17, 2021, 04:28 PM |
| CAHILL EDWARD L | Director | Feb 18, 2021 | Sale | $72.00 | 10,000 | 720,026 | 62,591 | Feb 19, 2021, 07:51 PM |
| Altier Thomas | Chief Financial Officer | Feb 19, 2021 | Sale | $72.83 | 904 | 65,834 | 81,083 | Feb 19, 2021, 07:37 PM |
| Altier Thomas | Chief Financial Officer | Feb 18, 2021 | Sale | $71.96 | 76,272 | 5,488,349 | 97,310 | Feb 19, 2021, 07:37 PM |
| VanDuyn Amy Beth | SVP, Human Resources | Jan 29, 2021 | Option Exercise | $0.84 | 18,204 | 15,291 | 73,838 | Feb 02, 2021, 04:34 PM |
| VanDuyn Amy Beth | SVP, Human Resources | Jan 29, 2021 | Sale | $65.91 | 21,829 | 1,438,762 | 70,688 | Feb 02, 2021, 04:34 PM |
| Altier Thomas | Chief Financial Officer | Jan 22, 2021 | Sale | $69.69 | 1,495 | 104,184 | 158,774 | Jan 26, 2021, 05:50 PM |
| Indig Chaim | Chief Executive Officer | Jan 20, 2021 | Option Exercise | $4.71 | 14,892 | 70,141 | 1,139,677 | Jan 22, 2021, 05:34 PM |
| Indig Chaim | Chief Executive Officer | Jan 20, 2021 | Sale | $66.06 | 14,892 | 983,720 | 1,138,677 | Jan 22, 2021, 05:34 PM |
| Linetsky David | SVP, Life Sciences | Jan 20, 2021 | Sale | $66.04 | 6,826 | 450,798 | 148,922 | Jan 22, 2021, 05:32 PM |
| Altier Thomas | Chief Financial Officer | Jan 17, 2021 | Option Exercise | $62.96 | 780 | 49,109 | 164,254 | Jan 20, 2021, 08:33 PM |
| Altier Thomas | Chief Financial Officer | Jan 15, 2021 | Option Exercise | $62.96 | 2,604 | 163,948 | 165,034 | Jan 20, 2021, 08:33 PM |
| Altier Thomas | Chief Financial Officer | Jan 19, 2021 | Sale | $64.00 | 4,704 | 301,076 | 159,550 | Jan 20, 2021, 08:33 PM |
| Weintraub Michael | Director | Jan 19, 2021 | Option Exercise | $2.03 | 35,000 | 71,050 | 199,484 | Jan 20, 2021, 08:31 PM |
| Weintraub Michael | Director | Jan 19, 2021 | Sale | $63.86 | 35,000 | 2,235,113 | 181,702 | Jan 20, 2021, 08:31 PM |
| Linetsky David | SVP, Life Sciences | Jan 17, 2021 | Option Exercise | $62.96 | 277 | 17,440 | 154,602 | Jan 20, 2021, 08:31 PM |
| Linetsky David | SVP, Life Sciences | Jan 15, 2021 | Option Exercise | $62.96 | 1,787 | 112,510 | 154,879 | Jan 20, 2021, 08:31 PM |
| Linetsky David | SVP, Life Sciences | Jan 19, 2021 | Sale | $64.28 | 5,136 | 330,119 | 149,466 | Jan 20, 2021, 08:31 PM |
| VanDuyn Amy Beth | SVP, Human Resources | Jan 17, 2021 | Option Exercise | $62.96 | 334 | 21,029 | 55,634 | Jan 20, 2021, 08:28 PM |
| VanDuyn Amy Beth | SVP, Human Resources | Jan 15, 2021 | Option Exercise | $62.96 | 1,005 | 63,275 | 55,968 | Jan 20, 2021, 08:28 PM |
| Indig Chaim | Chief Executive Officer | Jan 17, 2021 | Option Exercise | $62.96 | 25,073 | 1,578,596 | 1,124,785 | Jan 20, 2021, 08:28 PM |
| Indig Chaim | Chief Executive Officer | Jan 15, 2021 | Option Exercise | $62.96 | 7,138 | 449,408 | 1,149,858 | Jan 20, 2021, 08:28 PM |
| Indig Chaim | Chief Executive Officer | Jan 19, 2021 | Option Exercise | $2.03 | 59,986 | 121,772 | 1,184,771 | Jan 20, 2021, 08:28 PM |
| Indig Chaim | Chief Executive Officer | Jan 15, 2021 | Option Exercise | $2.03 | 75,122 | 152,498 | 1,176,528 | Jan 20, 2021, 08:28 PM |
| Indig Chaim | Chief Executive Officer | Jan 15, 2021 | Sale | $62.81 | 75,122 | 4,718,293 | 1,170,314 | Jan 20, 2021, 08:28 PM |
| Indig Chaim | Chief Executive Officer | Jan 19, 2021 | Sale | $63.95 | 59,986 | 3,836,099 | 1,173,999 | Jan 20, 2021, 08:28 PM |
| Roberts Evan | Chief Operating Officer | Jan 17, 2021 | Option Exercise | $62.96 | 872 | 54,901 | 608,608 | Jan 20, 2021, 08:27 PM |
| Roberts Evan | Chief Operating Officer | Jan 15, 2021 | Option Exercise | $62.96 | 4,496 | 283,068 | 609,480 | Jan 20, 2021, 08:27 PM |
| Roberts Evan | Chief Operating Officer | Jan 19, 2021 | Sale | $63.87 | 5,500 | 351,299 | 603,408 | Jan 20, 2021, 08:27 PM |
| Roberts Evan | Chief Operating Officer | Jan 05, 2021 | Option Exercise | $4.71 | 575 | 2,708 | 606,855 | Jan 06, 2021, 08:39 PM |
| Roberts Evan | Chief Operating Officer | Jan 05, 2021 | Sale | $53.43 | 21,468 | 1,146,967 | 590,580 | Jan 06, 2021, 08:39 PM |
| Roberts Evan | Chief Operating Officer | Jan 04, 2021 | Sale | $52.48 | 80,245 | 4,211,615 | 656,797 | Jan 06, 2021, 08:39 PM |
| Smith Mark Douglas | Director | Jan 04, 2021 | Option Exercise | $4.71 | 6,000 | 28,260 | 12,110 | Jan 06, 2021, 08:34 PM |
| Smith Mark Douglas | Director | Jan 04, 2021 | Sale | $52.57 | 6,000 | 315,411 | 9,199 | Jan 06, 2021, 08:34 PM |
| VanDuyn Amy Beth | SVP, Human Resources | Jan 04, 2021 | Option Exercise | $0.84 | 500 | 420 | 44,767 | Jan 06, 2021, 08:32 PM |
| VanDuyn Amy Beth | SVP, Human Resources | Jan 04, 2021 | Sale | $54.26 | 500 | 27,128 | 44,267 | Jan 06, 2021, 08:32 PM |
| CAHILL EDWARD L | Director | Dec 24, 2020 | Sale | $57.22 | 24,370 | 1,394,481 | 70,709 | Dec 28, 2020, 05:12 PM |
| Pegus Cheryl | Director | Dec 16, 2020 | Option Exercise | $11.89 | 20,764 | 246,884 | 47,922 | Dec 18, 2020, 05:14 PM |
| Pegus Cheryl | Director | Dec 17, 2020 | Sale | $56.15 | 8,415 | 472,492 | 16,775 | Dec 18, 2020, 05:14 PM |
| Pegus Cheryl | Director | Dec 16, 2020 | Sale | $55.83 | 22,732 | 1,269,089 | 25,190 | Dec 18, 2020, 05:14 PM |
| Altier Thomas | Chief Financial Officer | Oct 22, 2020 | Option Exercise | $0.84 | 86,237 | 72,439 | 246,728 | Oct 26, 2020, 05:55 PM |
| Altier Thomas | Chief Financial Officer | Oct 23, 2020 | Option Exercise | $0.84 | 8,669 | 7,282 | 169,160 | Oct 26, 2020, 05:55 PM |
| Altier Thomas | Chief Financial Officer | Oct 23, 2020 | Sale | $38.21 | 8,669 | 331,207 | 160,491 | Oct 26, 2020, 05:55 PM |
| Altier Thomas | Chief Financial Officer | Oct 22, 2020 | Sale | $37.65 | 86,237 | 3,246,547 | 160,491 | Oct 26, 2020, 05:55 PM |
| Altier Thomas | Chief Financial Officer | Oct 12, 2020 | Sale | $32.13 | 6,779 | 217,779 | 160,491 | Oct 14, 2020, 07:24 PM |
| Linetsky David | SVP, Life Sciences | Oct 01, 2020 | Option Exercise | $4.71 | 1,377 | 6,486 | 132,554 | Oct 05, 2020, 06:49 PM |
| Linetsky David | SVP, Life Sciences | Oct 01, 2020 | Sale | $30.97 | 4,477 | 138,667 | 128,332 | Oct 05, 2020, 06:49 PM |
| Roberts Evan | Chief Operating Officer | Oct 01, 2020 | Sale | $30.93 | 14,774 | 456,952 | 686,525 | Oct 05, 2020, 06:48 PM |
| Altier Thomas | Chief Financial Officer | Sep 11, 2020 | Option Exercise | $0.84 | 6,779 | 5,694 | 121,760 | Sep 15, 2020, 06:33 PM |
| Altier Thomas | Chief Financial Officer | Sep 11, 2020 | Sale | $27.99 | 6,779 | 189,712 | 115,015 | Sep 15, 2020, 06:33 PM |
| Kallenbach Charles | General Counsel & Secretary | Aug 17, 2020 | Option Exercise | $2.55 | 2,500 | 6,375 | 41,650 | Aug 20, 2020, 07:32 PM |
| Kallenbach Charles | General Counsel & Secretary | Aug 17, 2020 | Sale | $29.84 | 2,500 | 74,593 | 39,150 | Aug 20, 2020, 07:32 PM |
| Smith Mark Douglas | Director | Aug 10, 2020 | Option Exercise | $4.71 | 6,000 | 28,260 | 12,110 | Aug 12, 2020, 06:01 PM |
| Smith Mark Douglas | Director | Aug 10, 2020 | Sale | $30.30 | 6,000 | 181,825 | 6,110 | Aug 12, 2020, 06:01 PM |
| Altier Thomas | Chief Financial Officer | Aug 11, 2020 | Option Exercise | $0.84 | 6,779 | 5,694 | 121,760 | Aug 12, 2020, 05:59 PM |
| Altier Thomas | Chief Financial Officer | Aug 11, 2020 | Sale | $30.10 | 6,779 | 204,035 | 115,481 | Aug 12, 2020, 05:59 PM |
| Nathan Daniel | Chief Technology Officer | Jul 31, 2020 | Option Exercise | $0.69 | 7,000 | 4,830 | 65,196 | Aug 04, 2020, 06:22 PM |
| Nathan Daniel | Chief Technology Officer | Jul 31, 2020 | Sale | $30.03 | 8,804 | 264,391 | 56,392 | Aug 04, 2020, 06:22 PM |
| CAHILL EDWARD L | Director | Jul 21, 2020 | Sale | $29.02 | 9,080 | 263,520 | 46,467 | Jul 22, 2020, 06:35 PM |
| Kallenbach Charles | General Counsel & Secretary | Jul 17, 2020 | Option Exercise | $2.55 | 2,500 | 6,375 | 41,650 | Jul 21, 2020, 06:49 PM |
| Kallenbach Charles | General Counsel & Secretary | Jul 17, 2020 | Sale | $29.29 | 2,500 | 73,233 | 39,150 | Jul 21, 2020, 06:49 PM |
| Nathan Daniel | Chief Technology Officer | Jul 17, 2020 | Option Exercise | $0.84 | 38,683 | 32,494 | 46,646 | Jul 21, 2020, 06:49 PM |
| Nathan Daniel | Chief Technology Officer | Jul 17, 2020 | Sale | $29.25 | 38,683 | 1,131,431 | 7,963 | Jul 21, 2020, 06:49 PM |
| Roberts Evan | Chief Operating Officer | Jul 01, 2020 | Sale | $28.45 | 12,500 | 355,623 | 701,299 | Jul 06, 2020, 06:07 PM |
| Linetsky David | SVP, Life Sciences | Jul 01, 2020 | Option Exercise | $4.71 | 1,376 | 6,481 | 135,652 | Jul 06, 2020, 06:01 PM |
| Linetsky David | SVP, Life Sciences | Jul 01, 2020 | Sale | $28.24 | 4,475 | 126,396 | 131,177 | Jul 06, 2020, 06:01 PM |
| Kallenbach Charles | General Counsel & Secretary | Jun 17, 2020 | Option Exercise | $2.55 | 2,500 | 6,375 | 41,650 | Jun 19, 2020, 05:06 PM |
| Kallenbach Charles | General Counsel & Secretary | Jun 17, 2020 | Sale | $29.26 | 2,500 | 73,145 | 39,150 | Jun 19, 2020, 05:06 PM |
| Munson Gillian | Director | Jun 12, 2020 | Sale | $28.32 | 5,000 | 141,600 | 16,048 | Jun 16, 2020, 06:15 PM |
| Davidoff Michael J. | See Remarks | Jun 11, 2020 | Option Exercise | $0.84 | 13,084 | 10,991 | 124,087 | Jun 15, 2020, 06:07 PM |
| Davidoff Michael J. | See Remarks | Apr 09, 2020 | Option Exercise | $8.03 | 4,284 | 34,401 | 115,287 | Jun 15, 2020, 06:05 PM |
| Davidoff Michael J. | See Remarks | Apr 09, 2020 | Sale | $20.10 | 4,284 | 86,121 | 111,003 | Jun 15, 2020, 06:05 PM |
| Davidoff Michael J. | See Remarks | Apr 01, 2020 | Option Exercise | $8.03 | 1,404 | 11,274 | 112,407 | Jun 15, 2020, 06:02 PM |
| Davidoff Michael J. | See Remarks | Apr 01, 2020 | Sale | $20.13 | 1,404 | 28,264 | 111,003 | Jun 15, 2020, 06:02 PM |
| Kallenbach Charles | General Counsel & Secretary | May 18, 2020 | Option Exercise | $2.55 | 2,500 | 6,375 | 41,650 | May 20, 2020, 07:43 PM |
| Kallenbach Charles | General Counsel & Secretary | May 18, 2020 | Sale | $27.20 | 2,500 | 68,000 | 39,150 | May 20, 2020, 07:43 PM |
| Linetsky David | SVP, Life Sciences | May 07, 2020 | Sale | $26.00 | 255 | 6,630 | 134,276 | May 11, 2020, 04:43 PM |
| Indig Chaim | Chief Executive Officer | Apr 30, 2020 | Option Exercise | $23.67 | 3,672 | 86,916 | 1,101,406 | May 04, 2020, 08:47 PM |
| Altier Thomas | Chief Financial Officer | Apr 30, 2020 | Option Exercise | $23.67 | 710 | 16,806 | 116,077 | May 04, 2020, 08:43 PM |
| Altier Thomas | Chief Financial Officer | May 01, 2020 | Sale | $24.34 | 1,096 | 26,674 | 114,981 | May 04, 2020, 08:43 PM |
| Linetsky David | SVP, Life Sciences | Apr 30, 2020 | Option Exercise | $23.67 | 786 | 18,605 | 134,531 | May 04, 2020, 08:41 PM |
| Kallenbach Charles | General Counsel & Secretary | Apr 30, 2020 | Option Exercise | $23.67 | 337 | 7,977 | 39,150 | May 04, 2020, 08:41 PM |
| Roberts Evan | Chief Operating Officer | Apr 30, 2020 | Option Exercise | $23.67 | 795 | 18,818 | 713,799 | May 04, 2020, 08:40 PM |
| Nathan Daniel | Chief Technology Officer | Apr 30, 2020 | Option Exercise | $23.67 | 1,470 | 34,795 | 58,196 | May 04, 2020, 08:38 PM |
| VanDuyn Amy Beth | SVP, Human Resources | Apr 30, 2020 | Option Exercise | $23.67 | 625 | 14,794 | 44,267 | May 04, 2020, 08:37 PM |
| VanDuyn Amy Beth | SVP, Human Resources | May 01, 2020 | Option Exercise | $2.03 | 13,474 | 27,352 | 57,741 | May 04, 2020, 08:37 PM |
| VanDuyn Amy Beth | SVP, Human Resources | May 01, 2020 | Sale | $24.88 | 13,474 | 335,186 | 53,841 | May 04, 2020, 08:37 PM |
| Linetsky David | SVP, Life Sciences | Apr 27, 2020 | Option Exercise | $4.71 | 1,376 | 6,481 | 137,731 | Apr 29, 2020, 04:44 PM |
| Linetsky David | SVP, Life Sciences | Apr 27, 2020 | Sale | $26.00 | 4,220 | 109,720 | 133,511 | Apr 29, 2020, 04:44 PM |
| Kallenbach Charles | General Counsel & Secretary | Apr 23, 2020 | Option Exercise | $2.55 | 5,000 | 12,750 | 43,461 | Apr 27, 2020, 04:48 PM |
| Kallenbach Charles | General Counsel & Secretary | Apr 23, 2020 | Sale | $25.00 | 5,000 | 125,000 | 38,461 | Apr 27, 2020, 04:48 PM |
| Davidoff Michael J. | See Remarks | Apr 09, 2020 | Sale | $20.10 | 4,285 | 86,141 | 105,314 | Apr 13, 2020, 05:24 PM |
| Davidoff Michael J. | See Remarks | Apr 01, 2020 | Sale | $20.13 | 1,404 | 28,264 | 109,599 | Apr 03, 2020, 05:05 PM |
| Davidoff Michael J. | See Remarks | Mar 30, 2020 | Sale | $20.00 | 689 | 13,780 | 111,003 | Apr 01, 2020, 05:35 PM |
| Davidoff Michael J. | See Remarks | Mar 27, 2020 | Option Exercise | $0.79 | 31,856 | 25,052 | 111,692 | Mar 30, 2020, 04:49 PM |
| Davidoff Michael J. | See Remarks | Mar 26, 2020 | Sale | $20.06 | 3,851 | 77,262 | 79,836 | Mar 30, 2020, 04:49 PM |
| Davidoff Michael J. | See Remarks | Mar 23, 2020 | Sale | $20.06 | 700 | 14,045 | 83,687 | Mar 25, 2020, 05:19 PM |
| Linetsky David | SVP, Life Sciences | Mar 13, 2020 | Option Exercise | $0.83 | 50,060 | 41,322 | 136,355 | Mar 17, 2020, 05:04 PM |
| VanDuyn Amy Beth | SVP, Human Resources | Mar 13, 2020 | Option Exercise | $0.69 | 6,826 | 4,710 | 43,086 | Mar 17, 2020, 05:02 PM |
| Roberts Evan | Chief Operating Officer | Mar 13, 2020 | Option Exercise | $0.84 | 25,000 | 21,000 | 712,788 | Mar 17, 2020, 05:00 PM |
| Indig Chaim | Chief Executive Officer | Mar 12, 2020 | Option Exercise | $0.84 | 100,000 | 84,000 | 1,098,180 | Mar 16, 2020, 04:40 PM |
| Roberts Evan | Chief Operating Officer | Mar 09, 2020 | Option Exercise | $0.84 | 50,000 | 42,000 | 687,788 | Mar 10, 2020, 05:23 PM |
| Davidoff Michael J. | See Remarks | Mar 02, 2020 | Option Exercise | $4.71 | 17,066 | 80,381 | 101,453 | Mar 04, 2020, 05:07 PM |
| Davidoff Michael J. | See Remarks | Mar 02, 2020 | Sale | $29.85 | 17,066 | 509,351 | 91,338 | Mar 04, 2020, 05:07 PM |
| Kallenbach Charles | General Counsel & Secretary | Feb 19, 2020 | Option Exercise | $2.55 | 50 | 127 | 38,511 | Feb 21, 2020, 04:26 PM |
| Kallenbach Charles | General Counsel & Secretary | Feb 19, 2020 | Sale | $32.85 | 50 | 1,642 | 38,461 | Feb 21, 2020, 04:26 PM |
| Nathan Daniel | Chief Technology Officer | Feb 19, 2020 | Sale | $33.70 | 9,142 | 308,107 | 56,920 | Feb 21, 2020, 04:26 PM |
| Nathan Daniel | Chief Technology Officer | Feb 18, 2020 | Option Exercise | $0.73 | 6,826 | 4,983 | 75,123 | Feb 20, 2020, 04:59 PM |
| Nathan Daniel | Chief Technology Officer | Feb 18, 2020 | Sale | $32.82 | 9,061 | 297,398 | 66,062 | Feb 20, 2020, 04:59 PM |
| Kallenbach Charles | General Counsel & Secretary | Feb 18, 2020 | Option Exercise | $2.55 | 2,450 | 6,247 | 40,911 | Feb 20, 2020, 04:50 PM |
| Kallenbach Charles | General Counsel & Secretary | Feb 18, 2020 | Sale | $32.82 | 2,450 | 80,413 | 38,461 | Feb 20, 2020, 04:50 PM |
| Linetsky David | SVP, Life Sciences | Feb 18, 2020 | Sale | $32.85 | 3,188 | 104,718 | 86,639 | Feb 20, 2020, 04:49 PM |
| Weintraub Michael | Director | Feb 12, 2020 | Option Exercise | $2.03 | 10,680 | 21,680 | 169,054 | Feb 14, 2020, 05:19 PM |
| Weintraub Michael | Director | Feb 12, 2020 | Sale | $32.51 | 10,680 | 347,198 | 158,374 | Feb 14, 2020, 05:19 PM |
| Weintraub Michael | Director | Feb 10, 2020 | Option Exercise | $2.03 | 15,177 | 30,809 | 173,551 | Feb 12, 2020, 08:32 PM |
| Weintraub Michael | Director | Feb 11, 2020 | Option Exercise | $2.03 | 9,143 | 18,560 | 167,517 | Feb 12, 2020, 08:32 PM |
| Weintraub Michael | Director | Feb 11, 2020 | Sale | $33.02 | 9,143 | 301,925 | 158,374 | Feb 12, 2020, 08:32 PM |
| Weintraub Michael | Director | Feb 10, 2020 | Sale | $32.79 | 15,177 | 497,620 | 158,374 | Feb 12, 2020, 08:32 PM |
| VanDuyn Amy Beth | SVP, Human Resources | Feb 10, 2020 | Option Exercise | $0.73 | 6,826 | 4,983 | 43,086 | Feb 12, 2020, 08:31 PM |
| VanDuyn Amy Beth | SVP, Human Resources | Feb 10, 2020 | Sale | $32.84 | 6,826 | 224,175 | 36,260 | Feb 12, 2020, 08:31 PM |
| Altier Thomas | Chief Financial Officer | Feb 10, 2020 | Option Exercise | $2.03 | 266 | 540 | 125,936 | Feb 12, 2020, 08:30 PM |
| Altier Thomas | Chief Financial Officer | Feb 10, 2020 | Sale | $32.85 | 10,955 | 359,873 | 114,981 | Feb 12, 2020, 08:30 PM |
| Davidoff Michael J. | See Remarks | Feb 06, 2020 | Sale | $33.10 | 4,550 | 150,585 | 84,587 | Feb 12, 2020, 08:23 PM |
| Davidoff Michael J. | See Remarks | Feb 06, 2020 | Sale | $33.10 | 4,550 | 150,585 | 84,587 | Feb 10, 2020, 06:15 PM |
| Indig Chaim | Chief Executive Officer | Feb 06, 2020 | Option Exercise | $2.03 | 80,000 | 162,400 | 1,078,180 | Feb 10, 2020, 06:14 PM |
| Indig Chaim | Chief Executive Officer | Feb 06, 2020 | Sale | $33.11 | 80,000 | 2,648,928 | 998,180 | Feb 10, 2020, 06:14 PM |
| Indig Chaim | Chief Executive Officer | Feb 03, 2020 | Option Exercise | $2.03 | 55,953 | 113,585 | 1,070,823 | Feb 05, 2020, 05:14 PM |
| Indig Chaim | Chief Executive Officer | Feb 04, 2020 | Option Exercise | $2.03 | 44,047 | 89,415 | 1,058,917 | Feb 05, 2020, 05:14 PM |
| Indig Chaim | Chief Executive Officer | Feb 03, 2020 | Sale | $30.81 | 55,953 | 1,724,002 | 1,022,678 | Feb 05, 2020, 05:14 PM |
| Indig Chaim | Chief Executive Officer | Feb 04, 2020 | Sale | $31.44 | 60,737 | 1,909,681 | 998,180 | Feb 05, 2020, 05:14 PM |
| Davidoff Michael J. | See Remarks | Feb 03, 2020 | Option Exercise | $2.03 | 11,377 | 23,095 | 100,314 | Feb 05, 2020, 04:58 PM |
| Davidoff Michael J. | See Remarks | Feb 03, 2020 | Sale | $30.90 | 11,377 | 351,603 | 91,403 | Feb 05, 2020, 04:58 PM |
| Roberts Evan | Chief Operating Officer | Jan 27, 2020 | Option Exercise | $2.03 | 5,445 | 11,053 | 707,236 | Feb 05, 2020, 04:56 PM |
| Roberts Evan | Chief Operating Officer | Jan 27, 2020 | Sale | $29.17 | 69,448 | 2,026,132 | 637,788 | Feb 05, 2020, 04:56 PM |
| Roberts Evan | Chief Operating Officer | Jan 27, 2020 | Sale | $29.17 | 69,448 | 2,026,132 | 632,343 | Jan 28, 2020, 05:44 PM |
| Indig Chaim | Chief Executive Officer | Jan 24, 2020 | Option Exercise | $27.83 | 8,909 | 247,937 | 1,014,870 | Jan 27, 2020, 06:47 PM |
| Davidoff Michael J. | See Remarks | Jan 24, 2020 | Option Exercise | $27.83 | 449 | 12,496 | 88,937 | Jan 27, 2020, 06:46 PM |
| Roberts Evan | Chief Operating Officer | Jan 24, 2020 | Option Exercise | $27.83 | 449 | 12,496 | 701,791 | Jan 27, 2020, 06:43 PM |
| Linetsky David | SVP, Life Sciences | Jan 24, 2020 | Option Exercise | $27.83 | 225 | 6,262 | 89,483 | Jan 27, 2020, 06:41 PM |
| VanDuyn Amy Beth | SVP, Human Resources | Jan 24, 2020 | Option Exercise | $27.83 | 197 | 5,483 | 36,260 | Jan 27, 2020, 06:40 PM |
| Nathan Daniel | Chief Technology Officer | Jan 24, 2020 | Option Exercise | $27.83 | 610 | 16,976 | 68,297 | Jan 27, 2020, 06:36 PM |
| Altier Thomas | Chief Financial Officer | Jan 24, 2020 | Option Exercise | $27.83 | 449 | 12,496 | 125,670 | Jan 27, 2020, 06:35 PM |
| Davidoff Michael J. | See Remarks | Jan 13, 2020 | Option Exercise | $1.46 | 21,210 | 30,889 | 43,233 | Jan 22, 2020, 09:58 PM |
| Linetsky David | See Remarks | Dec 30, 2019 | Option Exercise | $0.73 | 3,413 | 2,491 | 20,478 | Jan 22, 2020, 09:58 PM |
| Davidoff Michael J. | See Remarks | Dec 24, 2019 | Option Exercise | $0.73 | 1,545 | 1,128 | 22,023 | Jan 22, 2020, 09:57 PM |
| Davidoff Michael J. | See Remarks | Jan 13, 2020 | Option Exercise | $1.46 | 21,210 | 30,889 | 20,478 | Jan 14, 2020, 04:47 PM |
| Linetsky David | See Remarks | Dec 30, 2019 | Option Exercise | $0.73 | 3,413 | 2,491 | 17,065 | Jan 10, 2020, 05:11 PM |
| Davidoff Michael J. | See Remarks | Dec 24, 2019 | Option Exercise | $0.73 | 1,545 | 1,128 | 20,478 | Dec 27, 2019, 04:50 PM |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | Dec 17, 2019 | Sale | $24.48 | 2,360 | 57,770 | 21,245 | Dec 18, 2019, 04:50 PM |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | Dec 17, 2019 | Sale | $24.48 | 6,716 | 164,401 | 60,446 | Dec 18, 2019, 04:50 PM |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | Dec 17, 2019 | Sale | $24.48 | 344,599 | 8,435,439 | 3,101,386 | Dec 18, 2019, 04:50 PM |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | Dec 17, 2019 | Sale | $24.48 | 3,446 | 84,355 | 31,015 | Dec 18, 2019, 04:50 PM |
| Perricelli Scott | Director | Dec 17, 2019 | Sale | $24.48 | 2,000,000 | 48,958,000 | 3,618,234 | Dec 18, 2019, 04:28 PM |
| LLR Capital IV, LLC | 10% Owner | Dec 17, 2019 | Sale | $24.48 | 2,000,000 | 48,958,000 | 3,618,234 | Dec 18, 2019, 04:24 PM |
| Pegus Cheryl | Director | Dec 17, 2019 | Sale | $24.48 | 500,000 | 12,239,500 | 1,681,439 | Dec 18, 2019, 04:23 PM |
| HLM VENTURE PARTNERS II, L.P. | 10% Owner | Dec 17, 2019 | Sale | $24.48 | 2,181,577 | 53,402,824 | 2,016,938 | Dec 18, 2019, 04:21 PM |
| CAHILL EDWARD L | Director | Dec 17, 2019 | Sale | $24.48 | 2,181,577 | 53,402,824 | 2,016,938 | Dec 18, 2019, 04:17 PM |
| Indig Chaim | Chief Executive Officer | Dec 11, 2019 | Option Exercise | $0.84 | 3,800 | 3,192 | 831,472 | Dec 13, 2019, 04:01 PM |
| Altier Thomas | Chief Financial Officer | Dec 11, 2019 | Option Exercise | $0.84 | 41,666 | 34,999 | 53,043 | Dec 13, 2019, 04:00 PM |
| Roberts Evan | Chief Operating Officer | Dec 11, 2019 | Option Exercise | $0.84 | 3,800 | 3,192 | 586,856 | Dec 13, 2019, 04:00 PM |
| HLM VENTURE PARTNERS II, L.P. | 10% Owner | Jul 22, 2019 | Sale | $18.00 | 540,229 | 9,724,122 | 4,198,515 | Jul 24, 2019, 04:16 PM |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | Jul 22, 2019 | Sale | $18.00 | 3,828 | 68,904 | 34,461 | Jul 24, 2019, 04:16 PM |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | Jul 22, 2019 | Sale | $18.00 | 2,622 | 47,196 | 23,605 | Jul 24, 2019, 04:16 PM |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | Jul 22, 2019 | Sale | $18.00 | 7,462 | 134,316 | 67,162 | Jul 24, 2019, 04:16 PM |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | Jul 22, 2019 | Sale | $18.00 | 382,887 | 6,891,966 | 3,445,985 | Jul 24, 2019, 04:16 PM |
| CAHILL EDWARD L | Director | Jul 22, 2019 | Sale | $18.00 | 540,229 | 9,724,122 | 4,198,515 | Jul 24, 2019, 04:16 PM |
| CHV II, L.P. | 10% Owner | Jul 22, 2019 | Sale | $18.00 | 335,767 | 6,043,806 | 2,609,482 | Jul 24, 2019, 04:15 PM |
| Pegus Cheryl | Director | Jul 22, 2019 | Sale | $18.00 | 280,689 | 5,052,402 | 2,181,439 | Jul 24, 2019, 04:15 PM |
| LLR Capital IV, LLC | 10% Owner | Jul 22, 2019 | Sale | $18.00 | 743,388 | 13,380,984 | 5,533,962 | Jul 24, 2019, 04:15 PM |
| Perricelli Scott | Director | Jul 22, 2019 | Sale | $18.00 | 743,388 | 13,380,984 | 5,533,962 | Jul 24, 2019, 04:15 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Munson Gillian | Director | 05/16/2022 | 33,815 |
| Munson Gillian | Director | 05/09/2022 | 23,966 |
| Hoffman Allison C | General Counsel & Secretary | 05/09/2022 | 66,708 |
| Rasmussen Randy | Chief Financial Officer | 04/30/2022 | 21,782 |
| Munson Gillian | Director | 04/29/2022 | 8,740 |
| Goldstein Lainie | Director | 04/29/2022 | 8,740 |
| CAHILL EDWARD L | Director | 04/29/2022 | 8,740 |
| Indig Chaim | Chief Executive Officer | 04/14/2022 | 80,597 |
| Indig Chaim | Chief Executive Officer | 04/13/2022 | 268,827 |
| Roberts Evan | Chief Operating Officer | 04/14/2022 | 47,137 |
| Roberts Evan | Chief Operating Officer | 04/13/2022 | 135,721 |
| Rasmussen Randy | Chief Financial Officer | 04/13/2022 | 96,992 |
| Rasmussen Randy | Chief Financial Officer | 04/14/2022 | 33,681 |
| Davidoff Michael J. | SVP, Payer Business | 04/14/2022 | 21,911 |
| Davidoff Michael J. | SVP, Payer Business | 04/13/2022 | 58,983 |
| Linetsky David | SVP, Life Sciences | 04/14/2022 | 36,333 |
| Linetsky David | SVP, Life Sciences | 04/13/2022 | 64,757 |
| VanDuyn Amy Beth | SVP, Human Resources | 04/14/2022 | 11,384 |
| VanDuyn Amy Beth | SVP, Human Resources | 04/13/2022 | 22,496 |
| Hoffman Allison C | General Counsel & Secretary | 04/14/2022 | 31,167 |
| Hoffman Allison C | General Counsel & Secretary | 04/13/2022 | 117,736 |
| Rasmussen Randy | Chief Financial Officer | 03/26/2022 | 1,445 |
| Indig Chaim | Chief Executive Officer | 02/18/2022 | 399,990 |
| Goldstein Lainie | Director | 01/31/2022 | 8,733 |
| CAHILL EDWARD L | Director | 01/31/2022 | 8,733 |
| Roberts Evan | Chief Operating Officer | 01/21/2022 | 50,750 |
| Rasmussen Randy | Chief Financial Officer | 01/19/2022 | 72,767 |
| VanDuyn Amy Beth | SVP, Human Resources | 01/15/2022 | 84,040 |
| VanDuyn Amy Beth | SVP, Human Resources | 01/17/2022 | 17,811 |
| Davidoff Michael J. | See remarks | 01/17/2022 | 43,762 |
| Davidoff Michael J. | See remarks | 01/15/2022 | 149,701 |
| Hoffman Allison C | General Counsel & Secretary | 01/15/2022 | 31,248 |
| Rasmussen Randy | Chief Financial Officer | 01/15/2022 | 30,182 |
| Linetsky David | SVP, Life Sciences | 01/17/2022 | 14,789 |
| Linetsky David | SVP, Life Sciences | 01/15/2022 | 151,123 |
| Roberts Evan | Chief Operating Officer | 01/17/2022 | 61,964 |
| Roberts Evan | Chief Operating Officer | 01/15/2022 | 339,254 |
| Indig Chaim | Chief Executive Officer | 01/15/2022 | 655,471 |
| Indig Chaim | Chief Executive Officer | 01/17/2022 | 1,393,773 |
| Roberts Evan | Chief Operating Officer | 01/11/2022 | 36,750 |
| Indig Chaim | Chief Executive Officer | 01/07/2022 | 171,068 |
| Linetsky David | SVP, Life Sciences | 01/06/2022 | 164,659 |
| Rasmussen Randy | Chief Financial Officer | 12/31/2021 | 12,110 |
| Hoffman Allison C | General Counsel & Secretary | 12/31/2021 | 4,851 |
| Davidoff Michael J. | See remarks | 12/31/2021 | 30,139 |
| Roberts Evan | Chief Operating Officer | 12/09/2021 | 42,000 |
| Indig Chaim | Chief Executive Officer | 12/09/2021 | 101,500 |
| Rasmussen Randy | Chief Financial Officer | 11/09/2021 | 531,541 |
| Linetsky David | SVP, Life Sciences | 11/08/2021 | 7,060 |
| Linetsky David | SVP, Life Sciences | 11/05/2021 | 16,381 |
| Linetsky David | SVP, Life Sciences | 11/05/2021 | 261,382 |
| Linetsky David | SVP, Life Sciences | 11/08/2021 | 112,607 |
| Rasmussen Randy | Chief Financial Officer | 11/06/2021 | 211,244 |
| Linetsky David | SVP, Life Sciences | 11/01/2021 | 25,674 |
| Linetsky David | SVP, Life Sciences | 11/01/2021 | 386,362 |
| Goldstein Lainie | Director | 10/29/2021 | 8,747 |
| Goldstein Lainie | Director | 07/30/2021 | 8,749 |
| CAHILL EDWARD L | Director | 07/30/2021 | 8,749 |
| CAHILL EDWARD L | Director | 10/29/2021 | 8,747 |
| VanDuyn Amy Beth | SVP, Human Resources | 10/21/2020 | 18,840 |
| VanDuyn Amy Beth | SVP, Human Resources | 10/21/2020 | 379,190 |
| Linetsky David | SVP, Life Sciences | 10/15/2021 | 25,679 |
| Linetsky David | SVP, Life Sciences | 10/15/2021 | 356,334 |
| Linetsky David | SVP, Life Sciences | 08/31/2021 | 2,233 |
| Linetsky David | SVP, Life Sciences | 09/01/2021 | 23,446 |
| Linetsky David | SVP, Life Sciences | 08/31/2021 | 34,052 |
| Linetsky David | SVP, Life Sciences | 09/01/2021 | 350,535 |
| Linetsky David | SVP, Life Sciences | 08/27/2021 | 54,710 |
| Linetsky David | SVP, Life Sciences | 08/27/2021 | 1,541,599 |
| Indig Chaim | Chief Executive Officer | 08/30/2021 | 337,361 |
| Indig Chaim | Chief Executive Officer | 08/27/2021 | 271,089 |
| Indig Chaim | Chief Executive Officer | 08/27/2021 | 4,160,848 |
| Indig Chaim | Chief Executive Officer | 08/30/2021 | 3,900,870 |
| Linetsky David | SVP, Life Sciences | 08/25/2021 | 1,275 |
| Linetsky David | SVP, Life Sciences | 08/26/2021 | 2,040 |
| Linetsky David | SVP, Life Sciences | 08/26/2021 | 56,054 |
| Linetsky David | SVP, Life Sciences | 08/25/2021 | 35,019 |
| Indig Chaim | Chief Executive Officer | 08/26/2021 | 3,768 |
| Indig Chaim | Chief Executive Officer | 08/25/2021 | 2,826 |
| Indig Chaim | Chief Executive Officer | 08/26/2021 | 56,036 |
| Indig Chaim | Chief Executive Officer | 08/25/2021 | 42,018 |
| Hoffman Allison C | General Counsel & Secretary | 08/24/2021 | 179,205 |
| Hoffman Allison C | General Counsel & Secretary | 08/25/2021 | 143,762 |
| Weintraub Michael | Director | 08/05/2021 | 16,719 |
| Weintraub Michael | Director | 08/05/2021 | 577,552 |
| VanDuyn Amy Beth | SVP, Human Resources | 08/05/2021 | 366,877 |
| Indig Chaim | Chief Executive Officer | 08/05/2021 | 132,445 |
| Indig Chaim | Chief Executive Officer | 08/06/2021 | 7,819 |
| Indig Chaim | Chief Executive Officer | 08/06/2021 | 117,084 |
| Indig Chaim | Chief Executive Officer | 08/05/2021 | 1,976,006 |
| Indig Chaim | Chief Executive Officer | 07/29/2021 | 16,613 |
| Indig Chaim | Chief Executive Officer | 07/30/2021 | 480 |
| Indig Chaim | Chief Executive Officer | 07/29/2021 | 474,729 |
| Indig Chaim | Chief Executive Officer | 07/30/2021 | 7,140 |
| Weintraub Michael | Director | 07/29/2021 | 3,561 |
| Weintraub Michael | Director | 07/30/2021 | 20 |
| Weintraub Michael | Director | 07/30/2021 | 700 |
| Weintraub Michael | Director | 07/29/2021 | 122,821 |
| Weintraub Michael | Director | 07/21/2021 | 5,075 |
| Weintraub Michael | Director | 07/20/2021 | 15,225 |
| Weintraub Michael | Director | 07/21/2021 | 162,867 |
| Weintraub Michael | Director | 07/20/2021 | 488,137 |
| Weintraub Michael | Director | 07/16/2021 | 40,600 |
| Weintraub Michael | Director | 07/16/2021 | 1,275,202 |
| Munson Gillian | Director | 07/08/2021 | 193,044 |
| Roberts Evan | Chief Operating Officer | 06/28/2021 | 1,936,756 |
| Roberts Evan | Chief Operating Officer | 06/25/2021 | 110,210 |
| Roberts Evan | Chief Operating Officer | 06/24/2021 | 1,266,500 |
| CAHILL EDWARD L | Director | 06/24/2021 | 300,149 |
| Pegus Cheryl | Director | 05/24/2021 | 161,575 |
| Davidoff Michael J. | See Remarks | 04/09/2021 | 10,051 |
| Davidoff Michael J. | See Remarks | 04/09/2021 | 107,784 |
| Linetsky David | SVP, Life Sciences | 03/15/2021 | 2,964,510 |
| Linetsky David | SVP, Life Sciences | 03/16/2021 | 94,224 |
| CAHILL EDWARD L | Director | 02/18/2021 | 720,026 |
| Altier Thomas | Chief Financial Officer | 02/19/2021 | 65,834 |
| Altier Thomas | Chief Financial Officer | 02/18/2021 | 5,488,349 |
| VanDuyn Amy Beth | SVP, Human Resources | 01/29/2021 | 15,291 |
| VanDuyn Amy Beth | SVP, Human Resources | 01/29/2021 | 1,438,762 |
| Altier Thomas | Chief Financial Officer | 01/22/2021 | 104,184 |
| Indig Chaim | Chief Executive Officer | 01/20/2021 | 70,141 |
| Indig Chaim | Chief Executive Officer | 01/20/2021 | 983,720 |
| Linetsky David | SVP, Life Sciences | 01/20/2021 | 450,798 |
| Altier Thomas | Chief Financial Officer | 01/17/2021 | 49,109 |
| Altier Thomas | Chief Financial Officer | 01/15/2021 | 163,948 |
| Altier Thomas | Chief Financial Officer | 01/19/2021 | 301,076 |
| Weintraub Michael | Director | 01/19/2021 | 71,050 |
| Weintraub Michael | Director | 01/19/2021 | 2,235,113 |
| Linetsky David | SVP, Life Sciences | 01/17/2021 | 17,440 |
| Linetsky David | SVP, Life Sciences | 01/15/2021 | 112,510 |
| Linetsky David | SVP, Life Sciences | 01/19/2021 | 330,119 |
| VanDuyn Amy Beth | SVP, Human Resources | 01/17/2021 | 21,029 |
| VanDuyn Amy Beth | SVP, Human Resources | 01/15/2021 | 63,275 |
| Indig Chaim | Chief Executive Officer | 01/17/2021 | 1,578,596 |
| Indig Chaim | Chief Executive Officer | 01/15/2021 | 449,408 |
| Indig Chaim | Chief Executive Officer | 01/19/2021 | 121,772 |
| Indig Chaim | Chief Executive Officer | 01/15/2021 | 152,498 |
| Indig Chaim | Chief Executive Officer | 01/15/2021 | 4,718,293 |
| Indig Chaim | Chief Executive Officer | 01/19/2021 | 3,836,099 |
| Roberts Evan | Chief Operating Officer | 01/17/2021 | 54,901 |
| Roberts Evan | Chief Operating Officer | 01/15/2021 | 283,068 |
| Roberts Evan | Chief Operating Officer | 01/19/2021 | 351,299 |
| Roberts Evan | Chief Operating Officer | 01/05/2021 | 2,708 |
| Roberts Evan | Chief Operating Officer | 01/05/2021 | 1,146,967 |
| Roberts Evan | Chief Operating Officer | 01/04/2021 | 4,211,615 |
| Smith Mark Douglas | Director | 01/04/2021 | 28,260 |
| Smith Mark Douglas | Director | 01/04/2021 | 315,411 |
| VanDuyn Amy Beth | SVP, Human Resources | 01/04/2021 | 420 |
| VanDuyn Amy Beth | SVP, Human Resources | 01/04/2021 | 27,128 |
| CAHILL EDWARD L | Director | 12/24/2020 | 1,394,481 |
| Pegus Cheryl | Director | 12/16/2020 | 246,884 |
| Pegus Cheryl | Director | 12/17/2020 | 472,492 |
| Pegus Cheryl | Director | 12/16/2020 | 1,269,089 |
| Altier Thomas | Chief Financial Officer | 10/22/2020 | 72,439 |
| Altier Thomas | Chief Financial Officer | 10/23/2020 | 7,282 |
| Altier Thomas | Chief Financial Officer | 10/23/2020 | 331,207 |
| Altier Thomas | Chief Financial Officer | 10/22/2020 | 3,246,547 |
| Altier Thomas | Chief Financial Officer | 10/12/2020 | 217,779 |
| Linetsky David | SVP, Life Sciences | 10/01/2020 | 6,486 |
| Linetsky David | SVP, Life Sciences | 10/01/2020 | 138,667 |
| Roberts Evan | Chief Operating Officer | 10/01/2020 | 456,952 |
| Altier Thomas | Chief Financial Officer | 09/11/2020 | 5,694 |
| Altier Thomas | Chief Financial Officer | 09/11/2020 | 189,712 |
| Kallenbach Charles | General Counsel & Secretary | 08/17/2020 | 6,375 |
| Kallenbach Charles | General Counsel & Secretary | 08/17/2020 | 74,593 |
| Smith Mark Douglas | Director | 08/10/2020 | 28,260 |
| Smith Mark Douglas | Director | 08/10/2020 | 181,825 |
| Altier Thomas | Chief Financial Officer | 08/11/2020 | 5,694 |
| Altier Thomas | Chief Financial Officer | 08/11/2020 | 204,035 |
| Nathan Daniel | Chief Technology Officer | 07/31/2020 | 4,830 |
| Nathan Daniel | Chief Technology Officer | 07/31/2020 | 264,391 |
| CAHILL EDWARD L | Director | 07/21/2020 | 263,520 |
| Kallenbach Charles | General Counsel & Secretary | 07/17/2020 | 6,375 |
| Kallenbach Charles | General Counsel & Secretary | 07/17/2020 | 73,233 |
| Nathan Daniel | Chief Technology Officer | 07/17/2020 | 32,494 |
| Nathan Daniel | Chief Technology Officer | 07/17/2020 | 1,131,431 |
| Roberts Evan | Chief Operating Officer | 07/01/2020 | 355,623 |
| Linetsky David | SVP, Life Sciences | 07/01/2020 | 6,481 |
| Linetsky David | SVP, Life Sciences | 07/01/2020 | 126,396 |
| Kallenbach Charles | General Counsel & Secretary | 06/17/2020 | 6,375 |
| Kallenbach Charles | General Counsel & Secretary | 06/17/2020 | 73,145 |
| Munson Gillian | Director | 06/12/2020 | 141,600 |
| Davidoff Michael J. | See Remarks | 06/11/2020 | 10,991 |
| Davidoff Michael J. | See Remarks | 04/09/2020 | 34,401 |
| Davidoff Michael J. | See Remarks | 04/09/2020 | 86,121 |
| Davidoff Michael J. | See Remarks | 04/01/2020 | 11,274 |
| Davidoff Michael J. | See Remarks | 04/01/2020 | 28,264 |
| Kallenbach Charles | General Counsel & Secretary | 05/18/2020 | 6,375 |
| Kallenbach Charles | General Counsel & Secretary | 05/18/2020 | 68,000 |
| Linetsky David | SVP, Life Sciences | 05/07/2020 | 6,630 |
| Indig Chaim | Chief Executive Officer | 04/30/2020 | 86,916 |
| Altier Thomas | Chief Financial Officer | 04/30/2020 | 16,806 |
| Altier Thomas | Chief Financial Officer | 05/01/2020 | 26,674 |
| Linetsky David | SVP, Life Sciences | 04/30/2020 | 18,605 |
| Kallenbach Charles | General Counsel & Secretary | 04/30/2020 | 7,977 |
| Roberts Evan | Chief Operating Officer | 04/30/2020 | 18,818 |
| Nathan Daniel | Chief Technology Officer | 04/30/2020 | 34,795 |
| VanDuyn Amy Beth | SVP, Human Resources | 04/30/2020 | 14,794 |
| VanDuyn Amy Beth | SVP, Human Resources | 05/01/2020 | 27,352 |
| VanDuyn Amy Beth | SVP, Human Resources | 05/01/2020 | 335,186 |
| Linetsky David | SVP, Life Sciences | 04/27/2020 | 6,481 |
| Linetsky David | SVP, Life Sciences | 04/27/2020 | 109,720 |
| Kallenbach Charles | General Counsel & Secretary | 04/23/2020 | 12,750 |
| Kallenbach Charles | General Counsel & Secretary | 04/23/2020 | 125,000 |
| Davidoff Michael J. | See Remarks | 04/09/2020 | 86,141 |
| Davidoff Michael J. | See Remarks | 04/01/2020 | 28,264 |
| Davidoff Michael J. | See Remarks | 03/30/2020 | 13,780 |
| Davidoff Michael J. | See Remarks | 03/27/2020 | 25,052 |
| Davidoff Michael J. | See Remarks | 03/26/2020 | 77,262 |
| Davidoff Michael J. | See Remarks | 03/23/2020 | 14,045 |
| Linetsky David | SVP, Life Sciences | 03/13/2020 | 41,322 |
| VanDuyn Amy Beth | SVP, Human Resources | 03/13/2020 | 4,710 |
| Roberts Evan | Chief Operating Officer | 03/13/2020 | 21,000 |
| Indig Chaim | Chief Executive Officer | 03/12/2020 | 84,000 |
| Roberts Evan | Chief Operating Officer | 03/09/2020 | 42,000 |
| Davidoff Michael J. | See Remarks | 03/02/2020 | 80,381 |
| Davidoff Michael J. | See Remarks | 03/02/2020 | 509,351 |
| Kallenbach Charles | General Counsel & Secretary | 02/19/2020 | 127 |
| Kallenbach Charles | General Counsel & Secretary | 02/19/2020 | 1,642 |
| Nathan Daniel | Chief Technology Officer | 02/19/2020 | 308,107 |
| Nathan Daniel | Chief Technology Officer | 02/18/2020 | 4,983 |
| Nathan Daniel | Chief Technology Officer | 02/18/2020 | 297,398 |
| Kallenbach Charles | General Counsel & Secretary | 02/18/2020 | 6,247 |
| Kallenbach Charles | General Counsel & Secretary | 02/18/2020 | 80,413 |
| Linetsky David | SVP, Life Sciences | 02/18/2020 | 104,718 |
| Weintraub Michael | Director | 02/12/2020 | 21,680 |
| Weintraub Michael | Director | 02/12/2020 | 347,198 |
| Weintraub Michael | Director | 02/10/2020 | 30,809 |
| Weintraub Michael | Director | 02/11/2020 | 18,560 |
| Weintraub Michael | Director | 02/11/2020 | 301,925 |
| Weintraub Michael | Director | 02/10/2020 | 497,620 |
| VanDuyn Amy Beth | SVP, Human Resources | 02/10/2020 | 4,983 |
| VanDuyn Amy Beth | SVP, Human Resources | 02/10/2020 | 224,175 |
| Altier Thomas | Chief Financial Officer | 02/10/2020 | 540 |
| Altier Thomas | Chief Financial Officer | 02/10/2020 | 359,873 |
| Davidoff Michael J. | See Remarks | 02/06/2020 | 150,585 |
| Davidoff Michael J. | See Remarks | 02/06/2020 | 150,585 |
| Indig Chaim | Chief Executive Officer | 02/06/2020 | 162,400 |
| Indig Chaim | Chief Executive Officer | 02/06/2020 | 2,648,928 |
| Indig Chaim | Chief Executive Officer | 02/03/2020 | 113,585 |
| Indig Chaim | Chief Executive Officer | 02/04/2020 | 89,415 |
| Indig Chaim | Chief Executive Officer | 02/03/2020 | 1,724,002 |
| Indig Chaim | Chief Executive Officer | 02/04/2020 | 1,909,681 |
| Davidoff Michael J. | See Remarks | 02/03/2020 | 23,095 |
| Davidoff Michael J. | See Remarks | 02/03/2020 | 351,603 |
| Roberts Evan | Chief Operating Officer | 01/27/2020 | 11,053 |
| Roberts Evan | Chief Operating Officer | 01/27/2020 | 2,026,132 |
| Roberts Evan | Chief Operating Officer | 01/27/2020 | 2,026,132 |
| Indig Chaim | Chief Executive Officer | 01/24/2020 | 247,937 |
| Davidoff Michael J. | See Remarks | 01/24/2020 | 12,496 |
| Roberts Evan | Chief Operating Officer | 01/24/2020 | 12,496 |
| Linetsky David | SVP, Life Sciences | 01/24/2020 | 6,262 |
| VanDuyn Amy Beth | SVP, Human Resources | 01/24/2020 | 5,483 |
| Nathan Daniel | Chief Technology Officer | 01/24/2020 | 16,976 |
| Altier Thomas | Chief Financial Officer | 01/24/2020 | 12,496 |
| Davidoff Michael J. | See Remarks | 01/13/2020 | 30,889 |
| Linetsky David | See Remarks | 12/30/2019 | 2,491 |
| Davidoff Michael J. | See Remarks | 12/24/2019 | 1,128 |
| Davidoff Michael J. | See Remarks | 01/13/2020 | 30,889 |
| Linetsky David | See Remarks | 12/30/2019 | 2,491 |
| Davidoff Michael J. | See Remarks | 12/24/2019 | 1,128 |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | 12/17/2019 | 57,770 |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | 12/17/2019 | 164,401 |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | 12/17/2019 | 8,435,439 |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | 12/17/2019 | 84,355 |
| Perricelli Scott | Director | 12/17/2019 | 48,958,000 |
| LLR Capital IV, LLC | 10% Owner | 12/17/2019 | 48,958,000 |
| Pegus Cheryl | Director | 12/17/2019 | 12,239,500 |
| HLM VENTURE PARTNERS II, L.P. | 10% Owner | 12/17/2019 | 53,402,824 |
| CAHILL EDWARD L | Director | 12/17/2019 | 53,402,824 |
| Indig Chaim | Chief Executive Officer | 12/11/2019 | 3,192 |
| Altier Thomas | Chief Financial Officer | 12/11/2019 | 34,999 |
| Roberts Evan | Chief Operating Officer | 12/11/2019 | 3,192 |
| HLM VENTURE PARTNERS II, L.P. | 10% Owner | 07/22/2019 | 9,724,122 |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | 07/22/2019 | 68,904 |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | 07/22/2019 | 47,196 |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | 07/22/2019 | 134,316 |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | 07/22/2019 | 6,891,966 |
| CAHILL EDWARD L | Director | 07/22/2019 | 9,724,122 |
| CHV II, L.P. | 10% Owner | 07/22/2019 | 6,043,806 |
| Pegus Cheryl | Director | 07/22/2019 | 5,052,402 |
| LLR Capital IV, LLC | 10% Owner | 07/22/2019 | 13,380,984 |
| Perricelli Scott | Director | 07/22/2019 | 13,380,984 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Load More
Period of Report: 10/31/2021
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
07/31/2021
3.43%
1Q
04/30/2021
9.97%
2Q
01/31/2021
26.38%
3Q
10/31/2020
31.93%
4Q
07/31/2020
33.10%
5Q
04/30/2020
33.87%
6Q
Load More